The Northern Ireland MHRA Authorised Route (NIMAR)

The document provides guidance for key stakeholders in the medicines supply chain. It aims to facilitate their use of the NIMAR regulatory route, enabling the continued supply of Great Britain (GB) licensed medicines to Northern Ireland (NI). This guidance is intended for industry and trade organizations, wholesalers, logistics providers, and healthcare professionals involved in the supply chain. The document's purpose is to inform stakeholders about the requirements and procedures for using the NIMAR regulatory route effectively.